Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia

NCT02402998 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Primacy Immune Thrombocytopenia

Interventions

DRUG: Eltrombopag

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto